Carla Vizzotti launched the pediatric vaccination campaign against Covid-19 from six months at the Garrahan hospital

The Minister of Health of the Nation, Carla Vizzotti, launched today at the «Prof. Dr. Juan P. Garrahan» the vaccination campaign against COVID-19 for girls and boys from 6 months to 3 years of age.

During her visit, the head of the national health portfolio highlighted the importance of incorporating the only age group that did not yet have a vaccine into the National Vaccination Campaign against COVID-19. “This is a very relevant novelty and in this way Argentina becomes one of the first countries to be able to protect this population,” she revealed.

Vizzotti also reported that 645,600 pediatric doses from the Moderna laboratory have already been distributed to all provinces and there are more than 2,000,000 vaccines in stock that will be sent to the different jurisdictions as the vaccination plan progresses.

In turn, the minister recommended the co-administration of the COVID-19 vaccines with the other vaccines on the National Calendar, which can be administered on the same day or on different days, without requiring an interval between doses. “The ideal is that the application be carried out in the vaccination clinics, to take advantage of the opportunity and complete missed schemes,” she added.

On the other hand, the head of the health portfolio also highlighted the recent publication by the prestigious scientific journal Cell Reports Medicine of a study prepared by specialists from CONICET and the Ministry of Health that proves that the application of heterologous schemes with different platforms of Vaccines to combat the SARS-CoV-2 virus induce an antibody response equal to or greater than that provided by homologous doses.

“We continue to work and generate scientific evidence on timely decisions that we made and that helped a lot in our vaccination campaign,” the minister completed.

Moderna’s mRNA-1273 platform SARS COV-2 mRNA vaccine has the immunogenicity, efficacy, and safety for administration with a primary schedule of two doses administered 28 days apart.

The initial scheme in children from 6 months to 2 years, 11 months and 29 days contemplates 2 doses of the mRNA platform vaccine against SARS COV-2 from the Moderna laboratory, separated by 28 days, as for girls and boys of 3 and 4 years without primary scheme. While in girls and boys aged 3 and 4 years with a complete initial scheme, the application of a booster dose is recommended, 120 days after completing the initial scheme.

In this sense, during the visit to the Garrahan Hospital, the Undersecretary for Health Strategies, Juan Manuel Castelli, highlighted that “the studies carried out demonstrated the high levels of efficacy and, above all, the safety of this vaccine, which obtained the approval of the regulatory agency of the United States (FDA) and the ANMAT in Argentina”. In addition, he stressed that this vaccination strategy has the endorsement and support of the National Immunization Commission (CoNaIn), scientific societies, and especially the Argentine Pediatric Society (SAP).

You might be interested in reading: Carla Vizzotti, participated in a training for provincial health teams on monkeypox

With this launch, Argentina becomes one of the first countries in the world and the first in Latin America to incorporate this age group into the vaccination strategy against COVID-19. This will allow that, although outbreaks continue to occur, vaccination has a positive impact and avoids complications when they present the disease, with the possibility of hospitalizations and the need for intensive care.

The Secretary for Access to Health, Sandra Tirado; the Undersecretary for Health Strategies, Juan Manuel Castelli; the undersecretary of Medicines and Strategic Information, Natalia Grinblat; the president of the Garrahan Hospital Board of Directors, Gabriela Bauer; the deputy medical director of the Garrahan Hospital, Darío Barsotti; the coordinator of the Garrahan Hospital Vaccination Center, Adriana Parra; the head of the Epidemiology and Infectology Service, Rosa Bologna; Board members, directors, pediatricians, and members of the nursing team.

Leave a Comment